Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors

0.50 hr(s) | CME

Therapeutic Area(s): Hematology, Benign , Oncology

Release Date: December 31, 2021

Expiration Date: December 30, 2022

Location: Internet Activity Enduring

In this activity, an expert in hematology-oncology provides an overview of paroxysmal nocturnal hemoglobinuria (PNH) and discusses current and emerging treatment options for managing PNH.

Access this activity
Share via
Copy link
Powered by Social Snap